Association of 20q13.2 copy number changes with the advanced stage of ovarian cancer - Tissue microarray analysis

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 118, Issue 1, 2005, Pages 81-85

  Dimova, I ^a   Yosifova, A ^a   Zaharieva, B ^a   Raitcheva, S ^b   Doganov, N ^b   Toncheva, D ^a  

^a MEDICAL UNIVERSITY OF SOFIA   (Bulgaria)

^b UNIVERSITY HOSPITAL ALEXANDROVSKA   (Bulgaria)

Author keywords

20q13.2; Fluorescence in situ hybridization; Ovarian cancer; Tissue microchips

Indexed keywords

ARTICLE; CANCER STAGING; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE SEVERITY; DNA MICROARRAY; FEMALE; FLUORESCENCE IN SITU HYBRIDIZATION; GENE AMPLIFICATION; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MUTATION; OVARY CANCER; PHENOTYPE; PRIORITY JOURNAL; PROGNOSIS; STATISTICAL SIGNIFICANCE;

EID: 10644257285     PISSN: 03012115     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2004.06.007     Document Type: Article

References (29)

1. A. Kallioniemi, O.-P. Kallioniemi, J. Piper, M. Tanner, T. Stokke, and L. Chen Detection and mapping of amplified DNA sequences in breast cancer by comparative genomic hybridization Proc. Natl. Acad. Sci. U.S.A. 91 1994 2156 2160
2. J.J. Isola, O.-P. Kallioniemi, L.W. Chu, S.A.W. Fuqua, S.G. Helsenbeck, and C.K. Osborne Genetic aberrations detected by comparative genomic hybridization predict outcome in node-negative breast cancer Am. J. Pathol. 147 1995 905 911
3. M. Trikkonen, O. Johannssin, B.A. Agnarsson, H. Ollsson, S. Igvarsson, and R. Karhu Distinct somatic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germline mutations Cancer Res. 57 1997 1222 1227
4. T. Ried, R. Knutzen, R. Steinbeck, H. Blegen, E. Schrock, and K. Heselmeyer Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors Genes Chromosomes Cancer 15 1996 243 245
5. A. Kokkola, O. Monni, P. Puolakkainen, M.L. Larramendy, M. Victorzon, and S. Nording 17q12-21 amplicon, a novel recurrent genetic change in intestinal type gastric carcinoma: a comparative genomic hybridization study Genes Chromosomes Cancer 20 1997 38 43
6. M. Tarkkanen, I. Elomaa, C. Blomqvist, A. Kivioja, T. Bohling, and J. Valle DNA sequence copy number increase at 8q: a new prognostic marker in high-grade osteosarcoma Int. J. Cancer 84 2 1999 114 121
7. M.L. Larramendy, J. Tapper, H. Pere, W. El-Rifai, S. Hemmer, and V.M. Wasenium DNA copy number amplifications in human neoplasms: review of comparaive genomic hybridizaion studies Am. J. Pathol. 152 1998 1107 1123
8. M.M. Tanner, M. Tirkkonen, A. Kallioniemi, J. Isola, T. Kuukasjarvi, and C. Collins Independent amplification and frequent co-amplification of three nonsyntetic regions on the long arm of chromosome 20 in human breast cancer Cancer Res. 56 1996 3441 3445
9. S.L. Anzick, J. Kononen, R.L. Walker, D.O. Azorsa, M.M. Tanner, and X.-Y. Guan AIB1, a steroid receptor coactivator amplified in breast and ovarian cancer Science 277 1997 965 968
10. S. Sen, H. Zhou, and R.A. White A putative serine/threonine kinase encoding gene BTAK on chromosome 20q13 is amplified and overexpressed in human breast cancer cell lines Oncogene 14 1997 21955 22000
11. N. Hashimoto, and B.J. Goldstein Differential regulation of mRNA encoding three protein-tyrosine phosphatases by insulin and activation of protein kinase C Biochem. Biophys. Res. Commun. 188 1992 1305 1311
12. J.R. Wiener, B.J. Kerns, E.L. Harvey, M.R. Conaway, J.D. Iglehart, and A. Berchuk Overexpression of the protein tyrosine phosphatase PTP1B in human breast cancer: association with p185c-erbB-2 protein expression J. Natl. Cancer Inst. 86 1994 372 378
13. K. Noben-Trauth, N.G. Copeland, D.J. Gilbert, N.A. Jenkins, G. Sonoda, and J.R. Testa Myb12 (Bmyb) maps to mouse chromosome 2 and human chromosome 20q13.1 Genomics 35 1996 610 612
14. U. Brinkmann, M. Gallo, M.H. Polymeropoulos, and I. Pastan The human CAS (cellular apoptosis susceptibility) gene mapping on chromosome 20q13 is amplified in BT474 breast cancer cells and part of aberrant chromosomes inn breast and colon cancer cell lines Genome Res. 6 1996 187 194
15. S. Hauptmann, C. Denkert, I. Koch, S. Petersen, K. Schluns, and A. Reles Genetic alterations in epithelial ovarian tumors analyzed by comparative genomic hybridization Hum. Pathol. 33 6 2002 632 641
16. J. Bayani, J.D. Brenton, P.F. Macgregor, B. Beheshti, M. Albert, and D. Nallainathan Parallel analysis of sporadic primary ovarian carcinomas by spectral karyotyping, comparative genomic hybridization, and expression microarrays Cancer Res. 62 12 2002 3466 3476
17. T. Watanabe, I. Imoto, Y. Kosugi, I. Ishiwata, S. Inoue, and M. Takayama A novel amplification at 17q21-23 in ovarian cancer cell lines detected by comparative genomic hybridization Gynecol. Oncol. 81 2 2001 172 177
18. M. Kiechle, A. Jacobsen, U. Schwarz-Boeger, J. Hedderich, J. Pfisterer, and N. Arnold Comparative genomic hybridization detects genetic imbalances in primary ovarian carcinomas as correlated with grade of differentiation Cancer 91 3 2001 534 540
19. G. Sonoda, J. Palazzo, S. du-Manoir, A.K. Godwin, M. Feder, and M. Yakushiji Comparative genomic hybridization detects frequent overrepresentation of chromosomal material from 3q26, 8q24, and 20q13 in human ovarian carcinomas Genes Chromosomes Cancer 20 4 1997 320 328
20. S. Suzuki, D.H. Moore II, D.G. Ginzinger, T.E. Godfrey, J. Barclay, and B. Powell An approach to analysis of large-scale correlations between genome changes and clinical endpoints in ovarian cancer Cancer Res. 60 19 2000 5382 5385
21. Y. Suehiro, M. Sakamoto, K. Umayahara, H. Iwabuchi, H. Sakamoto, and N. Tanaka Genetic aberrations detected by comparative genomic hybridization in ovarian clear cell adenocarcinomas Oncology 59 1 2000 50 56
22. R.P. Zweemer, A. Ryan, A.M. Snijders, M.A. Hermsen, G.A. Meijer, and U. Beller Comparative genomic hybridization of microdissected familial ovarian carcinoma: two deleted regions on chromosome 15q not previously identified in sporadic ovarian carcinoma Lab. Invest. 81 10 2001 1363 1370
23. J. Diebold Phenotype-genotype-correlation in ovarian neoplasia Verh. Dtsch. Ges. Pathol. 85 2001 153 160
24. T. Watanabe, I. Imoto, T. Katahira, A. Hirasawa, I. Ishiwata, and M. Emi Differentially regulated genes as putative targets of amplifications at 20q in ovarian cancers Jpn. J. Cancer Res. 93 10 2002 1114 1122
25. J. Diebold, K. Mosinger, G. Peiro, U. Pannekamp, C. Kaltz, and G.B. Baretton 20q13 and cyclin D1 in ovarian carcinomas. Analysis by fluorescence in situ hybridization J. Pathol. 190 5 2000 564 571
26. J. Kononen, L. Bubendorf, and A. Kallioniemi Tissue microarray for high-throughput molecular profiling of hundreds of specimens Nat. Med. 4 1998 844 847
27. Kurman RJ, editor. Blaustein's pathology of the female genital tract. 4th ed. 1994;705-939.
28. A.A. Jazaeri, K. Lu, R. Schmandt, C.P. Harris, P.H. Rao, and C. Sotiriou Molecular determinants of tumor differentiation in papillary serous ovarian carcinoma Carcinogenesis 36 2 2003 53 59
29. G. Peiro, J. Diebold, and U. Lohrs CAS (cellular apoptosis susceptibility) gene expression in ovarian carcinoma: correlation with 20q13.2 copy number and cyclin D1, p53, and Rb protein expression Am. J. Clin. Pathol. 118 6 2002 922 929